Meeting report on the first Sino-Dutch symposium on oncology

On October 31, 2015, the first Sino-Dutch symposium on oncology was organized in Guangzhou (China). The symposium revealed similarities between Chinese and Dutch efforts to improve the care of tumor patients and to create enhanced insight into the nature of cancers. In particular, it became evident...

Descripción completa

Detalles Bibliográficos
Autor principal: Peppelenbosch, Maikel P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
News and Views
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4794864/
https://www.ncbi.nlm.nih.gov/pubmed/26983406
http://dx.doi.org/10.1186/s40880-016-0093-3
_version_ 1782421537532411904
author Peppelenbosch, Maikel P.
author_facet Peppelenbosch, Maikel P.
author_sort Peppelenbosch, Maikel P.
collection PubMed
description On October 31, 2015, the first Sino-Dutch symposium on oncology was organized in Guangzhou (China). The symposium revealed similarities between Chinese and Dutch efforts to improve the care of tumor patients and to create enhanced insight into the nature of cancers. In particular, it became evident for some types of cancer that immunotherapy should focus on counteracting interleukin-17-associated immunity and targeting cancer stroma. Targeting specific cancer microenvironment and stroma also opens new therapeutic options, including the use of radio-active theranostics and live tumor imaging-guided surgeries.
format Online
Article
Text
id pubmed-4794864
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-47948642016-03-17 Meeting report on the first Sino-Dutch symposium on oncology Peppelenbosch, Maikel P. Chin J Cancer News and Views On October 31, 2015, the first Sino-Dutch symposium on oncology was organized in Guangzhou (China). The symposium revealed similarities between Chinese and Dutch efforts to improve the care of tumor patients and to create enhanced insight into the nature of cancers. In particular, it became evident for some types of cancer that immunotherapy should focus on counteracting interleukin-17-associated immunity and targeting cancer stroma. Targeting specific cancer microenvironment and stroma also opens new therapeutic options, including the use of radio-active theranostics and live tumor imaging-guided surgeries. BioMed Central 2016-03-16 /pmc/articles/PMC4794864/ /pubmed/26983406 http://dx.doi.org/10.1186/s40880-016-0093-3 Text en © Peppelenbosch. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle News and Views
Peppelenbosch, Maikel P.
Meeting report on the first Sino-Dutch symposium on oncology
title Meeting report on the first Sino-Dutch symposium on oncology
title_full Meeting report on the first Sino-Dutch symposium on oncology
title_fullStr Meeting report on the first Sino-Dutch symposium on oncology
title_full_unstemmed Meeting report on the first Sino-Dutch symposium on oncology
title_short Meeting report on the first Sino-Dutch symposium on oncology
title_sort meeting report on the first sino-dutch symposium on oncology
topic News and Views
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4794864/
https://www.ncbi.nlm.nih.gov/pubmed/26983406
http://dx.doi.org/10.1186/s40880-016-0093-3
work_keys_str_mv AT peppelenboschmaikelp meetingreportonthefirstsinodutchsymposiumononcology

Ejemplares similares